FDA Import Refusal AEK-5992058-4/11/1 — Natco Pharma Limited
The FDA refused shipment AEK-5992058-4/11/1 from Natco Pharma Limited (India) on May 23, 2019. The refused product falls under Drugs and Biologics — REVLIMID. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 23, 2019
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61CCE03 REVLIMID
- Charges
- 75